• Single-Cell Insights Into Ciprofloxacin-Tetracycline Antagon

  2026-07-09

  This study provides a mechanistic explanation for the antagonistic interaction between ciprofloxacin hydrochloride and tetracycline at the single-cell level. Using microfluidic analysis, researchers demonstrated that tetracycline suppresses ciprofloxacin-induced cell death by modulating the bacterial SOS response, with implications for optimizing antibiotic combinations in both research and clinical contexts.

• E-64d: Precision Cysteine Protease Inhibition for Cell Death

  2026-07-09

  E-64d empowers researchers with robust, membrane-permeable inhibition of intracellular cysteine proteases, enabling precise dissection of calpain and cathepsin roles in both apoptosis and lysoptosis. Its superior cell penetration and irreversibility set a new standard for reproducibility in regulated cell death assays, especially where conventional inhibitors fall short.

• Perifosine (KRX-0401): Precision Akt/mTOR Inhibition in Canc

  2026-07-08

  Perifosine (KRX-0401), supplied by APExBIO, empowers researchers with robust, reproducible inhibition of the Akt/mTOR pathway for apoptosis and radiosensitization studies. This guide details experimental setups, workflow optimization, and troubleshooting strategies, leveraging the latest mechanistic insights into apoptosis and neuroprotection.

• Irinotecan (CPT-11): Mechanisms, Assay Optimization, and Fut

  2026-07-08

  Explore Irinotecan's (CPT-11) unique mechanism as a topoisomerase I inhibitor and its advanced applications in DNA damage and apoptosis induction in colorectal cancer research. This article offers deep technical insight and practical guidance beyond current oncology protocols.

• Leupeptin Hemisulfate Salt: Precision in Protease Activity R

  2026-07-07

  Leupeptin hemisulfate salt transforms protease activity regulation with nanomolar potency and proven reliability in protein degradation and viral replication studies. This guide details protocol optimization, cross-domain insights, and troubleshooting strategies, leveraging both recent research and benchmark applications.

• Recombinant Annexin V for Sensitive Detection of Apoptotic C

  2026-07-07

  This study details robust methods for expressing and purifying recombinant annexin V, enabling precise detection of apoptosis via membrane phosphatidylserine externalization. The innovations support high-yield protein production and standardized apoptosis assays, with implications for research in cell death and membrane dynamics.

• NMDA (N-Methyl-D-aspartic acid): Applied Workflows in Excito

  2026-07-06

  NMDA (N-Methyl-D-aspartic acid) is the gold standard for modeling excitotoxicity and ferroptosis in neurodegeneration and glaucoma workflows. This guide unpacks advanced protocols, troubleshooting, and key innovations that make APExBIO’s NMDA the trusted choice for reproducibility and data-driven insight.

• BFH772 (VEGFR2 inhibitor): Technical Use and Workflow Guidan

  2026-07-06

  BFH772 is a potent, highly selective VEGFR2 inhibitor for research into VEGFR2-mediated angiogenesis, especially in tumor model systems. It is not suitable for workflows requiring water solubility or broad kinase inhibition, and careful attention to solubility and storage is essential for reproducible results.

• HDAC Inhibitors Potentiate Oncolytic Virus Therapy in Malign

  2026-07-05

  This study demonstrates that histone deacetylase inhibitors, including Panobinostat (LBH589), substantially enhance the efficacy of oncolytic herpes simplex virus (oHSV) therapy in models of malignant meningioma. The research provides mechanistic and translational insights into combination epigenetic and virotherapy strategies for aggressive brain tumors.

• Anlotinib Hydrochloride: Multi-Target Tyrosine Kinase Inhibi

  2026-07-04

  Anlotinib hydrochloride, a multi-target tyrosine kinase inhibitor, redefines angiogenesis research with superior inhibition of VEGFR2, PDGFRβ, and FGFR1. This article covers optimized protocols, troubleshooting, and strategic advantages for translational cancer studies leveraging APExBIO’s high-purity product.

• URB597 (KDS-4103): Elevating Endocannabinoid Research Precis

  2026-07-03

  URB597 (KDS-4103) stands out as a potent, selective FAAH inhibitor, enabling reproducible, high-fidelity endocannabinoid signaling modulation in translational pain and neuroplasticity research. This article unpacks advanced workflows, troubleshooting strategies, and key innovations from recent studies, ensuring your assays deliver actionable insights.

• Rhodamine B: Bridging Environmental Tracing and Cell Imaging

  2026-07-03

  This thought-leadership article explores Rhodamine B’s unique role as both a robust environmental fluorescent tracer and a high-fidelity cell labeling dye. Blending mechanistic insight with strategic guidance, it illuminates how translational researchers can harness Rhodamine B’s properties to drive precise, reproducible, and cross-domain fluorescence-based assays, from pesticide drift quantification to advanced cell imaging. The piece goes beyond standard product narratives by integrating recent mechanistic findings, protocol guidance, and a visionary outlook on cross-domain workflow maturity.

• Functional Genomic Screens Reveal Death-Regulatory Mechanism

  2026-07-02

  This study presents MEDUSA, a novel method for disentangling growth and death rates in pooled functional genomic screens, enabling precise identification of genes regulating cell death in response to drugs. By applying MEDUSA, the authors uncover how loss of p53 redirects DNA damage-induced cell death from apoptosis to a non-apoptotic, respiration-dependent mechanism, with significant implications for cancer research and therapeutic strategy development.

• Drug-Sensitized Yeast Platform Enhances mTOR Inhibitor Disco

  2026-07-02

  The referenced study introduces a highly sensitive yeast-based screening system for mTOR/TOR inhibitors, exploiting drug efflux gene deletions to detect pathway-specific inhibition at greatly reduced compound concentrations. This platform not only accelerates the identification of candidate geroprotective and anti-cancer agents but also provides a precise tool for verifying compound selectivity, as demonstrated with canagliflozin and other test molecules.

• Pseudo-UTP in Next-Gen mRNA Nanomedicine: Mechanisms and Pro

  2026-07-01

  Explore how pseudo-modified uridine triphosphate (Pseudo-UTP) drives innovation in mRNA nanomedicine, with a focus on practical protocol insights and mechanistic depth. This article uniquely connects advanced RNA modification to the latest breakthroughs in mRNA immunotherapy.

16111 records 1/1075 page Next 12345 下5页 Last page